Smithfield Trust’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Smithfield Trust’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-175	Closed	-$9K	–	1131
2020 Q3	$9K	Buy	+175	New	+$7.24K	﹤0.01%	804
2017 Q3	–	Sell	-463	Closed	-$8K	–	837
2017 Q2	$8K	Buy	463 +63	+16%	+$959	﹤0.01%	735
2017 Q1	$5K	Hold	400	–	–	﹤0.01%	747
2016 Q4	$6K	Hold	400	–	–	﹤0.01%	731
2016 Q3	$5K	Hold	400	–	–	﹤0.01%	768
2016 Q2	$4K	Hold	400	–	–	﹤0.01%	768
2016 Q1	$4K	Hold	400	–	–	﹤0.01%	775
2015 Q4	$6K	Hold	400	–	–	﹤0.01%	755
2015 Q3	$7K	Hold	400	–	–	﹤0.01%	717
2015 Q2	$9K	Hold	400	–	–	﹤0.01%	712
2015 Q1	$6K	Hold	400	–	–	﹤0.01%	729
2014 Q4	$5K	Hold	400	–	–	﹤0.01%	730
2014 Q3	$5K	Hold	400	–	–	﹤0.01%	763
2014 Q2	$5K	Buy	+400	New	+$4.72K	﹤0.01%	773

Smithfield Trust's MNTA Position: Q4 2020 in Review

Smithfield Trust sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 175 shares — an estimated $9K sold.

Smithfield Trust first reported a position in MNTA in Q2 2014 and held it in 14 quarters. The position peaked at $9K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Smithfield Trust reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Smithfield Trust sold 175 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $9K.
Smithfield Trust first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 14 quarters.
Smithfield Trust's Momenta Pharmaceuticals, Inc. position peaked at $9K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Smithfield Trust's 13F filing for Q4 2020, filed 12 Feb 2021.